Loading company…
Repairogen develops regenerative medicine therapies for tissue repair, orthopedic repair, wound healing and organ restoration.
Repairogen Corp. is a biotechnology firm developing regenerative medicine therapies that use proprietary techniques for tissue repair and regeneration. It sells these to hospitals, rehabilitation centers and specialty clinics, mainly in North America, Europe and parts of Asia, through subscriptions or one-time purchases. Founded in 2012 in Ithaca, US, the company has completed two deals, most recently a USD 1.000 mn Seed round in September 2017 led by Kairos Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in